Status: Recruiting
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
The primary objective of the ADDICT study is to assess and compare the clinical efficacy of available options for antimicrobial therapy (new beta-lactam/beta-lactamase inhibitor combination, cefiderocol or older agents such as aminoglycosides and colistin) in unselected patients with infection due to difficult-to-treat P. aeruginosa.
Participants needed: 600
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Centre Hospitalier Régional d'OrléansUpdated: Apr 30, 2026Locations: 48
Eligibility criteria
All patients aged 18 or over and requiring intravenous definite antimicrobial th...
Cystic fibrosis [+5]